The PerSeUS-BC01 study: A phase II study of nab-PTX followed by EC as neoadjuvant chemotherapy in breast cancer patients.

Manabu Futamura,Yasuko Nagao,Kazuhiro Ishihara,Makoto Takeuchi,Takumi Nakada,Yoshihiro Kawaguchi,Masayoshi Asano,Iwao Kumazawa,Takashi Shiroko,Ryutaro Mori,Kasumi Morimitsu,Masahito Nawa,Harumi Takahashi,Akemi Morikawa,Fumio Sakashita,Chika Takao,Yoshiki Hosono,Yoshimi Asano,Masako Kanematsu,Kazuhiro Yoshida

The PerSeUS-BC01 study: A phase II study of nab-PTX followed by EC as neoadjuvant chemotherapy in breast cancer patients.

2015

e12000 Background: A combination of anthracycline and taxane is a standard regimen for neoadjuvant chemotherapy (NAC) in breast cancer. Nab-PTX might have a higher pathological complete response (p...

Keywords:

Breast cancer
Pathology
Phases of clinical research
Oncology
Medicine
Internal medicine
Chemotherapy
Pathological
Taxane
Anthracycline
Regimen
complete response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations